Kaneka to Manufacture and Supply Intermediates for Shionogi COVID-19 Drug
SERAING, Belgium--(BUSINESS WIRE)--Kaneka Eurogentec, an FDA inspected contract development and manufacturing organization (CDMO), announced today that its mRNA manufacturing facility has successfully produced a 25 g batch of mRNA for a US customer.